Literature DB >> 12729408

Puberty in disorders of somatosexual differentiation.

Olaf Hiort1, Sandra Reinecke, Ute Thyen, Martina Jürgensen, Paul-Martin Holterhus, Daniela Schön, Hertha Richter-Appelt.   

Abstract

Despite enormous advances in the understanding of the molecular mechanisms of sexual differentiation, the medical decisions made in patients with disorders of somatosexual differentiation are mostly lacking evidence-based principles. Recent critical discussions have focused on approaches to gender assignment in infants with ambiguous genitalia. These decisions must be based on the correct diagnosis to be able to predict the development during puberty and adulthood in the affected individual. Puberty in this process plays a pivotal role not only because of the physical changes induced by endogenous or supplementary sex steroids to enhance the sex of rearing, but it is also the time for sexual orientation and promotion of gender identity. In this review we focus not only on the molecular impact of sex steroid action, but also view current opinions and studies on the gender development of the intersex patient during puberty.

Entities:  

Mesh:

Year:  2003        PMID: 12729408

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  8 in total

Review 1.  Management of disorders of sex development.

Authors:  Olaf Hiort; Wiebke Birnbaum; Louise Marshall; Lutz Wünsch; Ralf Werner; Tatjana Schröder; Ulla Döhnert; Paul-Martin Holterhus
Journal:  Nat Rev Endocrinol       Date:  2014-07-15       Impact factor: 43.330

Review 2.  Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major of dilemma.

Authors:  A D Fisher; J Ristori; E Fanni; G Castellini; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-06-10       Impact factor: 4.256

Review 3.  Clinical, endocrine, and molecular findings in 17beta-hydroxysteroid dehydrogenase type 3 deficiency.

Authors:  M F Faienza; L Giordani; M Delvecchio; L Cavallo
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

4.  17beta-Hydroxysteroid dehydrogenase-3 deficiency: from pregnancy to adolescence.

Authors:  S Bertelloni; A Balsamo; L Giordani; R Fischetto; G Russo; M Delvecchio; M Gennari; A Nicoletti; M C Maggio; D Concolino; L Cavallo; A Cicognani; G Chiumello; O Hiort; G I Baroncelli; M F Faienza
Journal:  J Endocrinol Invest       Date:  2009-05-12       Impact factor: 4.256

Review 5.  Disorders/Differences of Sex Development Presenting in the Newborn With 46,XY Karyotype.

Authors:  Silvano Bertelloni; Nina Tyutyusheva; Margherita Valiani; Franco D'Alberton; Fulvia Baldinotti; Maria Adelaide Caligo; Giampiero I Baroncelli; Diego G Peroni
Journal:  Front Pediatr       Date:  2021-04-22       Impact factor: 3.418

Review 6.  Different Clinical Presentations and Management in Complete Androgen Insensitivity Syndrome (CAIS).

Authors:  Lucia Lanciotti; Marta Cofini; Alberto Leonardi; Mirko Bertozzi; Laura Penta; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2019-04-09       Impact factor: 3.390

7.  The challenges of androgen insensitivity syndrome.

Authors:  Bratu Ovidiu; Dragos R Marcu; Dan L D Mischianu; Catalina Poiana; Camelia C Diaconu; Simona G Bungau; Delia M Tit; Alin Cumpanas; Roxana Bohiltea
Journal:  Arch Med Sci       Date:  2021-03-15       Impact factor: 3.707

8.  Severe Undervirilisation in a 46,XY Case Due to a Novel Mutation in HSD17B3 Gene.

Authors:  Ayfer Alikaşifoğlu; Doğuş Vurallı; Olaf Hiort; Nazlı Gönç; Alev Özön; Nurgün Kandemir
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.